Title

Biodegradability of naltrexone-poly(DL) lactide implants in vivo assessed under ultrasound in humans

Document Type

Article

Publication Date

2008

Abstract

Ultrasound was used to assess the in vivo biodegradability of a sustained release poly(DL)lactide naltrexone implant in 71 persons previously treated for heroin dependence. We assessed 139 implant sites ranging from 2 to 1808 days post implant. Ultrasound assessment showed that implant tablets were initially well demarcated from each other and from the surrounding tissues. Biodegradation resulted in less demarcated tablets followed by clumping into a single mass-like structure. This mass subsequently dispersed by approximately 1201 days post implant with no implant material visualized by ultrasound. The biodegradation was also assessed by visual clinical examination and palpation of the implant site as well as patient self-report. These measures were generally well correlated with ultrasound results. Clinical assessment of the biodegradation process concluded that the implant changed from ‘firm’ to ‘less firm’ and from ‘initial square edge’ to ‘rounded edge’ tablets. Collectively, these data provide direct evidence of the in vivo absorption of the Go Medical implant over time, and its biodegradability in humans.

G. Hulse, V. Low, V. Stalenberg, N. Morris, R. Thompson, R. Tait, C. Phan, Diane Arnold-Reed, 'Biodegradability of naltrexone-poly(DL) lactide implants in vivo assessed under ultrasound in humans', Addiction Biology, Vol. 13 (3/4), 2008 p. 364-374.

ISSN: 1355-6215

Copyright restrictions do not permit the upload of fulltext.

Current staff and students of the University of Notre Dame Australia can access the fulltext via the Library Catalogue at: http://search.ebscohost.com.ipacez.nd.edu.au/login.aspx?direct=true&db=aph&AN=33543616&site=ehost-live

Additional Files
University Copyright.pdf (130 kB)
University of Notre Dame Australia Copyright Statement